CRDF FY 2020 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$366,000+49.6% YoY

Gross Profit

$366,000100.0% margin

Operating Income

-$19M-5214.8% margin

Net Income

-$19M-5275.1% margin

EPS (Diluted)

$-1.08

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$135M

Total Liabilities

$7M

Stockholders' Equity

$128M

Cash & Equivalents

$131M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366,000	$244,632	+49.6%
Gross Profit	$366,000	$244,632	+49.6%
Operating Income	-$19M	-$17M	-14.4%
Net Income	-$19M	-$16M	-17.6%